THROMBOPOIETIN RECEPTOR AGONIST ELTROMBOPAG FOR ADVANCED MDS OR AML AND SEVERE THROMBOCYTOPENIA: 12-WEEK, RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 ASPIRE STUDY

被引：0
|
作者：
Mittelman, M. [1 ]
Platzbecker, U. [2 ]
Afanasyev, B. [3 ]
Grosicki, S. [4 ]
Wong, R. S. [5 ,6 ]
Anagnostopoulos, A. [7 ]
Brenner, B. [8 ]
Denzlinger, C. [9 ]
Rossi, G. [10 ]
Nagler, A. [11 ]
Garcia Delgado, R. [12 ]
Stone, N. [13 ]
Zhu, Z. [13 ]
Kalambakas, S. [13 ]
Selleslag, D. [14 ]
机构：
[1] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel
[2] Univ Klinikum Carl Gustav Carus, Dresden, Germany
[3] Pavlov State Med Univ, St Petersburg, Russia
[4] Silesian Med Univ, Katowice, Poland
[5] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, Shatin, Hong Kong, Peoples R China
[6] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China
[7] G Papanikolaou Gen Hosp, Thessaloniki, Greece
[8] Rambam Med Ctr, Haifa, Israel
[9] Marienhosp Stuttgart, Stuttgart, Germany
[10] Azienda Osped Spedali Civili, Brescia, Italy
[11] Chaim Sheba Med Ctr, Ramat Gan, Israel
[12] Hosp Virgen de la Victoria, Malaga, Spain
[13] Novartis Pharmaceut, E Hanover, NJ USA
[14] AZ St Jan Brugge AV, Brugge, Belgium
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S130
引用
收藏
页码：15 / 16
页数：2
相关论文
共 50 条
  • [31] Dose-finding study of luseogliflozin in Japanese patients with type 2 diabetes mellitus: a 12-week, randomized, double-blind, placebo-controlled, phase II study
    Seino, Yutaka
    Sasaki, Takashi
    Fukatsu, Atsushi
    Ubukata, Michito
    Sakai, Soichi
    Samukawa, Yoshishige
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (07) : 1231 - 1244
  • [32] Efficacy and tolerability of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers
    Nakamura, Masakazu
    Oshima, Akira
    Fujimoto, Yoko
    Maruyama, Nami
    Ishibashi, Taro
    Reeves, Karen R.
    CLINICAL THERAPEUTICS, 2007, 29 (06) : 1040 - 1056
  • [33] Oral insulin (ORMD-0801) in type 2 diabetes mellitus: A dose-finding 12-week randomized placebo-controlled study
    Eldor, Roy
    Francis, Bruce H. H.
    Fleming, Alexander
    Neutel, Joel
    Homer, Kenneth
    Kidron, Miriam
    Rosenstock, Julio
    DIABETES OBESITY & METABOLISM, 2023, 25 (04): : 943 - 952
  • [34] Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study
    Strowitzki, Thomas
    Faustmann, Thomas
    Gerlinger, Christoph
    Seitz, Christian
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 151 (02) : 193 - 198
  • [35] A 12-WEEK, RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED, PHASE 2B STUDY OF SAFETY, TOLERABILITY AND EFFICACY OF AR882 IN GOUT PATIENTS
    Wei, J. C. C.
    Fleischmann, R. M.
    Morris, S.
    Polvent, E.
    Shen, Z.
    Roche, A. Clouser
    Hingorani, V.
    Yan, S.
    Yeh, L. T.
    Keenan, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 192 - 192
  • [36] Late Breaking Abstract - Efficacy and safety of eliapixant in refractory chronic cough: Results of the PAGANINI 12-week, randomized, placebo-controlled Phase 2b study
    McGarvey, Lorcan
    Morice, Alyn H.
    Smith, Jaclyn
    Sher, Mandel
    Vaezi, Michael
    Guilleminault, Laurent
    Niimi, Akio
    Roth, Katrin
    Saarinen, Riitta
    Pires, Philippe Vieira
    Wosnitza, Melanie
    Dicpinigaitis, Peter
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [37] A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study
    Zanarini, Mary C.
    Schulz, S. Charles
    Detke, Holland C.
    Tanaka, Yoko
    Zhao, Fangyi
    Lin, Daniel
    Deberdt, Walter
    Kryzhanovskaya, Ludmila
    Corya, Sara
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (10) : 1353 - 1362
  • [38] A dose comparison of olanzapine for the treatment of borderline personality disorder: A 12-week randomized double-blind placebo-controlled study
    Zanarini, M. C.
    Schulz, S. C.
    Detke, H. C.
    Tanaka, Y.
    Zhao, F.
    Lin, D.
    DeBerdt, W.
    Corya, S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S191 - S191
  • [39] A dose comparison of olanzapine for the treatment of borderline personality disorder: A 12-week randomized double-blind placebo-controlled study
    Zanarini, M. C.
    Schulz, S. C.
    Detke, H. C.
    Tanaka, Y.
    Zhao, F.
    Lin, D.
    DeBerdt, W.
    Corya, S.
    EUROPEAN PSYCHIATRY, 2007, 22 : S172 - S173
  • [40] Fluoxetine Treatment of Alcoholic Perpetrators of Domestic Violence: A 12-Week, Double-Blind, Randomized, Placebo-Controlled Intervention Study
    George, David T.
    Phillips, Monte J.
    Lifshitz, Mariel
    Lionetti, Thomas A.
    Spero, David E.
    Ghassemzedeh, Niloofar
    Doty, Linda
    Umhau, John C.
    Rawlings, Robert R.
    JOURNAL OF CLINICAL PSYCHIATRY, 2011, 72 (01) : 60 - 65
12345